CD64 and Group II Secretory Phospholipase A2 (sPLA2-IIA) as Biomarkers for Distinguishing Adult Sepsis and Bacterial Infections in the Emergency Department.
<h4>Introduction</h4>Early diagnosis of sepsis and bacterial infection is imperative as treatment relies on early antibiotic administration. There is a need to develop new biomarkers to detect patients with sepsis and bacterial infection as early as possible, thereby enabling prompt anti...
Main Authors: | Toh Leong Tan, Nurul Saadah Ahmad, Dian Nasriana Nasuruddin, Azlin Ithnin, Khaizurin Tajul Arifin, Ida Zarina Zaini, Wan Zurinah Wan Ngah |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0152065 |
Similar Items
-
High sPLA2-IIA level is associated with eicosanoid metabolism in patients with bacterial sepsis syndrome.
by: Nurul Saadah Ahmad, et al.
Published: (2020-01-01) -
Comparison of sPLA2IIA performance with high-sensitive CRP neutrophil percentage PCT and lactate to identify bacterial infection
by: Toh Leong Tan, et al.
Published: (2021-05-01) -
An Amperometric Biosensor for the Determination of Bacterial Sepsis Biomarker, Secretory Phospholipase Group 2-IIA Using a Tri-Enzyme System
by: Nik Nurhanan Nik Mansor, et al.
Published: (2018-02-01) -
The role of group IIA secretory phospholipase A2 (sPLA2-IIA) as a biomarker for the diagnosis of sepsis and bacterial infection in adults-A systematic review.
by: Toh Leong Tan, et al.
Published: (2017-01-01) -
The genetic architecture of secretory PLA2 (sPLA2) genes and their impact on sPLA2 activity/mass and association with CHD risk
by: Exeter, H. J.
Published: (2012)